Boston Scientific Corp.
Padraig Andrew O'Connor (EVP, Global Operations) reports BSX insider transactions
About this filing
Boston Scientific Corp. (BSX) filed Form 4 (insider transaction) with the SEC on Sep 3, 2026. Form 4 reports a company insider’s trades in the company’s shares.
Key facts
- Insider
- Padraig Andrew O'Connor · EVP, Global Operations
| Date | Transaction | Shares | Price | Value | Held after | Ownership |
|---|---|---|---|---|---|---|
| Sep 2, 2026 | M · exercise or conversion of a derivativeFootnotes F1, F2 | +1,171 | $0.00 | $0.00 | 8,459 | Direct |
| Sep 2, 2026 | F · tax withholding | −567 | $48.37 | $27,425.79 | 7,892 | Direct |
| Sep 2, 2026 | M · exercise or conversion of a derivativeRestricted Stock UnitsFootnotes F1, F3 | −1,171 | $0.00 | $0.00 | 3,516 | Direct |
Footnotes
- F1 Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
- F2 Includes shares acquired under the Boston Scientific Employee Stock Purchase Plan based upon the most current data available.
- F3 Shares of common stock will be issued to the reporting person in four equal annual installments beginning on September 2, 2026, the first anniversary of the date of grant.
More BSX filings
- 8-K
Filed Oct 28, 2026
- 8-K
Filed Oct 7, 2026
- 8-K
Filed Sep 23, 2026
- 8-K
Filed Sep 8, 2026
- 4
Filed Aug 26, 2026
- 8-K
Filed Aug 26, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.